Pediatric Acute Myelogenous Leukemia (AML)
1 competing product in clinical development for Pediatric Acute Myelogenous Leukemia (AML).
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Decitabine + Decitabine | Eisai | Phase 2 | Terminated | 27 |